(PharmaNewsWire.Com, August 28, 2017 ) The Middle east and Africa HIV Diagnostics Market was worth USD 195.64 million in 2016 and estimated to be growing at a CAGR of 7.82%, to reach 285.17 million by 2021. The human immunodeficiency virus (HIV) refers to a kind of retrovirus that causes (AIDS).
HIV affects some immune cells and it weakens immune system bringing about loss of capacity to fight against the organisms that causes diseases. HIV spreads through exchange of fluids with some infected individual, for example, blood exchange or imparting needles to somebody who is HIV infected. HIV diagnostic market is developing at a significant rate because of increment in the HIV infected cases and developing awareness about the same. The present situation is like various POC/rapid tests are under clinical advancement and examination in the item pipelines of significant market members and are relied upon to acquire regulatory approval in various local segments of the market. This normal increment in the quantity of item offerings to the worldwide market space is required to fuel the development of the HIV diagnostics industry over the forecast period.
Major factors driving the market are, the technological advancement of disease diagnostic tests, and the foreseen improvement and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests; it is expected that all the major regional market segments will witness an expansion in market demand over the forecast period. There is a need to increase in introducing easily accessible, efficient robust diagnostics tests. Because of the financial resource constrained settings in a huge share of the disease affected regions it is as yet not feasible to perform the current, complex screening, staging and monitoring tests. This is either because of the absence of adequate testing labs or an absence of prepared clinical technicians capable of performing the tests. These limitations of laboratory based testing are a catalyst to the improvement of convenient and simple to execute point of care, rapid tests.
The Middle east and Africa HIV Diagnostics Market is categorized on the basis of Product, End-User, Type, and geography. Based on product, market is divided into Instruments, Consumables (Assays as well as Kits & Reagents, Other consumables), Software & Services]. Based on Type, market is segmented into HIV-2 & Group O Diagnostic Tests, Antibody Tests, Viral Identification Tests, CD4 Testing, Early Infant Diagnostics, Viral load testing. Further on the basis of Antibody tests market is divided into (HIV-1 Screening tests- Elisa/EIA, Home Access Dried blood spots, Rapid Tests), (HIV-1 Antibody Confirmatory Tests- Western Blot Test, Line immunoassays(Cnf), Indirect immunofluorescence Assays(IFA), Radio immunoprecipitation Assays(RIPA)). Based on HIV-2 & Group O Diagnostic Tests market is further segmented into Blood Antibody Tests, Line Immuno Assay (HIV-2), DBS Tests, and based on Viral Identification Tests, market is categorized into p24 Antigen Test, Viral Culture, Qualitative PCR Tests. On the basis of geography, the Middle east and Africa market is analyzed under various regions namely Middle-east, Africa
Some of the major companies dominating the market, by their products and services include Abbott Healthcare, Brsitol-Myers Squibb, Abbvie Inc., Alere Inc., Gilead Sciences, Merck & Co. Inc, Janssen Therapeutics, BD Biosciences, VIIV Healthcare, Partec, Sysmex, Beckman Coulter, Apogee Flow Systems, Zyomyx Inc., PointCare Technologies Inc., Mylan inc., Qiagen, Roche Diagnostics, Siemens Healthcare, and bioMerieux.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
